These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

204 related articles for article (PubMed ID: 19764780)

  • 1. Variability analysis of human plasma and cerebral spinal fluid reveals statistical significance of changes in mass spectrometry-based metabolomics data.
    Crews B; Wikoff WR; Patti GJ; Woo HK; Kalisiak E; Heideker J; Siuzdak G
    Anal Chem; 2009 Oct; 81(20):8538-44. PubMed ID: 19764780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantitative proteomics and metabolomics analysis of normal human cerebrospinal fluid samples.
    Stoop MP; Coulier L; Rosenling T; Shi S; Smolinska AM; Buydens L; Ampt K; Stingl C; Dane A; Muilwijk B; Luitwieler RL; Sillevis Smitt PA; Hintzen RQ; Bischoff R; Wijmenga SS; Hankemeier T; van Gool AJ; Luider TM
    Mol Cell Proteomics; 2010 Sep; 9(9):2063-75. PubMed ID: 20811074
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Elucidation of the complex metabolic profile of cerebrospinal fluid using an untargeted biochemical profiling assay.
    Kennedy AD; Pappan KL; Donti TR; Evans AM; Wulff JE; Miller LAD; Reid Sutton V; Sun Q; Miller MJ; Elsea SH
    Mol Genet Metab; 2017 Jun; 121(2):83-90. PubMed ID: 28412083
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Qualitative metabolome analysis of human cerebrospinal fluid by 13C-/12C-isotope dansylation labeling combined with liquid chromatography Fourier transform ion cyclotron resonance mass spectrometry.
    Guo K; Bamforth F; Li L
    J Am Soc Mass Spectrom; 2011 Feb; 22(2):339-47. PubMed ID: 21472593
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry.
    Carlsson H; Abujrais S; Herman S; Khoonsari PE; Åkerfeldt T; Svenningsson A; Burman J; Kultima K
    Metabolomics; 2020 Feb; 16(2):26. PubMed ID: 32052189
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study of the metabolomics characteristics of patients with metabolic syndrome based on liquid chromatography quadrupole time-of-flight mass spectrometry.
    Wu N; Wang W; Yi M; Cheng S; Wang D
    Ann Endocrinol (Paris); 2018 Feb; 79(1):37-44. PubMed ID: 29246383
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mass Accuracy Check Using Common Background Peaks for Improving Metabolome Data Quality in Chemical Isotope Labeling LC-MS.
    Li Y; Li L
    J Am Soc Mass Spectrom; 2019 Sep; 30(9):1733-1741. PubMed ID: 31140076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Translational Pharmacokinetic Rat Model of Cerebral Spinal Fluid and Plasma Concentrations of Cefepime.
    Avedissian SN; Pais G; Joshi MD; Rhodes NJ; Scheetz MH
    mSphere; 2019 Jan; 4(1):. PubMed ID: 30700511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of cerebrospinal fluid metabolites as biomarkers for neurobrucellosis by liquid chromatography-mass spectrometry approach.
    Yang H; Wang Z; Shi S; Yu Q; Liu M; Zhang Z
    Bioengineered; 2022 Mar; 13(3):6996-7010. PubMed ID: 35249459
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Urine metabolomics analysis based on ultra performance liquid chromatography-high resolution mass spectrometry combined with osmolality calibration sample concentration variability].
    He Z; Lin H; Gui J; Zhu W; He J; Wang H; Feng L
    Se Pu; 2021 Apr; 39(4):391-398. PubMed ID: 34227759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mealtime, temporal, and daily variability of the human urinary and plasma metabolomes in a tightly controlled environment.
    Kim K; Mall C; Taylor SL; Hitchcock S; Zhang C; Wettersten HI; Jones AD; Chapman A; Weiss RH
    PLoS One; 2014; 9(1):e86223. PubMed ID: 24475090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic phenotype of the healthy rodent model using in-vial extraction of dried serum, urine, and cerebrospinal fluid spots.
    Sen A; Wang Y; Chiu K; Whiley L; Cowan D; Chang RC; Legido-Quigley C
    Anal Chem; 2013 Aug; 85(15):7257-63. PubMed ID: 23845063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Protocol for Untargeted Metabolomic Analysis: From Sample Preparation to Data Processing.
    Souza AL; Patti GJ
    Methods Mol Biol; 2021; 2276():357-382. PubMed ID: 34060055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. LC-MS-Based Metabolomics of Biofluids Using All-Ion Fragmentation (AIF) Acquisition.
    Chaleckis R; Naz S; Meister I; Wheelock CE
    Methods Mol Biol; 2018; 1730():45-58. PubMed ID: 29363064
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cerebrospinal Fluid Metabolomics After Natural Product Treatment in an Experimental Model of Cerebral Ischemia.
    Huan T; Xian JW; Leung WN; Li L; Chan CW
    OMICS; 2016 Nov; 20(11):670-680. PubMed ID: 27732148
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Automated optimization of XCMS parameters for improved peak picking of liquid chromatography-mass spectrometry data using the coefficient of variation and parameter sweeping for untargeted metabolomics.
    Manier SK; Keller A; Meyer MR
    Drug Test Anal; 2019 Jun; 11(6):752-761. PubMed ID: 30479047
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overcoming Sample Matrix Effect in Quantitative Blood Metabolomics Using Chemical Isotope Labeling Liquid Chromatography Mass Spectrometry.
    Chen D; Han W; Su X; Li L; Li L
    Anal Chem; 2017 Sep; 89(17):9424-9431. PubMed ID: 28787119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Integrated analysis of ultra-deep proteomes in cortex, cerebrospinal fluid and serum reveals a mitochondrial signature in Alzheimer's disease.
    Wang H; Dey KK; Chen PC; Li Y; Niu M; Cho JH; Wang X; Bai B; Jiao Y; Chepyala SR; Haroutunian V; Zhang B; Beach TG; Peng J
    Mol Neurodegener; 2020 Jul; 15(1):43. PubMed ID: 32711556
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interlaboratory Reproducibility of a Targeted Metabolomics Platform for Analysis of Human Serum and Plasma.
    Siskos AP; Jain P; Römisch-Margl W; Bennett M; Achaintre D; Asad Y; Marney L; Richardson L; Koulman A; Griffin JL; Raynaud F; Scalbert A; Adamski J; Prehn C; Keun HC
    Anal Chem; 2017 Jan; 89(1):656-665. PubMed ID: 27959516
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.